SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 131 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2015. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,342,000 | +9.9% | 712,984 | -0.6% | 0.01% | 0.0% |
| Q3 2016 | $3,951,000 | +47.6% | 716,985 | +1.8% | 0.01% | +66.7% |
| Q2 2016 | $2,677,000 | +172.3% | 704,495 | +97.8% | 0.00% | +200.0% |
| Q1 2016 | $983,000 | -50.7% | 356,076 | +1.3% | 0.00% | -66.7% |
| Q4 2015 | $1,994,000 | +7.0% | 351,622 | +0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,863,000 | -37.0% | 351,545 | -1.3% | 0.00% | -25.0% |
| Q2 2015 | $2,956,000 | +134.8% | 356,145 | +30.7% | 0.00% | +100.0% |
| Q1 2015 | $1,259,000 | +51.7% | 272,460 | +0.2% | 0.00% | +100.0% |
| Q4 2014 | $830,000 | +8.5% | 272,034 | -1.0% | 0.00% | 0.0% |
| Q3 2014 | $765,000 | -30.3% | 274,752 | +1.8% | 0.00% | 0.0% |
| Q2 2014 | $1,098,000 | -7.7% | 269,807 | +20.4% | 0.00% | -50.0% |
| Q1 2014 | $1,190,000 | -5.9% | 224,131 | -0.2% | 0.00% | 0.0% |
| Q4 2013 | $1,265,000 | +21.4% | 224,614 | -1.4% | 0.00% | 0.0% |
| Q3 2013 | $1,042,000 | +14.5% | 227,916 | +8.2% | 0.00% | 0.0% |
| Q2 2013 | $910,000 | – | 210,561 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,273,509 | $9,493,000 | 1.85% |
| Trellus Management Company, LLC | 362,500 | $1,051,000 | 1.44% |
| Paulson & Co. | 24,062,368 | $69,781,000 | 1.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 971,922 | $2,799,000 | 1.09% |
| Asymmetry Capital Management, L.P. | 271,102 | $786,000 | 0.91% |
| Cheyne Capital Management (UK) LLP | 651,500 | $1,880,000 | 0.68% |
| Hikari Power Ltd | 1,500,000 | $4,350,000 | 0.56% |
| Orbimed Advisors | 13,621,443 | $39,502,000 | 0.38% |
| CARL DOMINO INC | 83,000 | $241,000 | 0.29% |
| KNOTT DAVID M | 158,400 | $459,000 | 0.20% |